Literature DB >> 10955662

Selective photoreceptor damage in albino rats using continuous blue light. A protocol useful for retinal degeneration and transplantation research.

M J Seiler1, O L Liu, N G Cooper, T L Callahan, H M Petry, R B Aramant.   

Abstract

PURPOSE: To develop a retinal degeneration model with selective photoreceptor loss and RPE sparing, to be used as recipient for evaluating retinal transplants.
METHODS: Albino rats were exposed to blue light, continuously, for 1-7 days (24-168 h) in a specially designed cage. Eyes were histologically analyzed at periods between 2 h and 8 months after the light exposure. Electroretinograms (ERGs) were recorded from some rats at 12-216 days after exposure. Using behavioral methods, visual thresholds of some rats were determined before exposure and re-measured between 18 and 52 days following exposure.
RESULTS: Apoptotic nuclei appeared exclusively in the photoreceptor layer after 1-5 days exposure to blue light. Light microscopy revealed that 2-4 days of light exposure reduced the outer nuclear layer (normally eight to ten rows) to 1 row of cells in the central retina and to two to three rows in the periphery, both in the superior and the inferior retina. Average ERG a- and b-wave amplitudes of light-damaged rats were both reduced by about 98%. Visual performance in the behavioral test was substantially impaired.
CONCLUSIONS: Continuous exposure of albino rats to moderate blue light for 2-5 days selectively eliminates most of the photoreceptors while leaving the RPE initially intact.

Entities:  

Mesh:

Year:  2000        PMID: 10955662     DOI: 10.1007/s004170000143

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

Review 1.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

2.  Acid-sensing ion channel 2 is important for retinal function and protects against light-induced retinal degeneration.

Authors:  Mohamed Ettaiche; Nicolas Guy; Paul Hofman; Michel Lazdunski; Rainer Waldmann
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

3.  Blue-light-blocking intraocular lens implantation improves the sleep quality of cataract patients.

Authors:  Xin Wei; Chunyan She; Danian Chen; Fangbing Yan; Jihong Zeng; Liping Zeng; Lin Wang
Journal:  J Clin Sleep Med       Date:  2013-08-15       Impact factor: 4.062

4.  Retinal ganglion cell axonal compression by retinal vessels in light-induced retinal degeneration.

Authors:  Diego García-Ayuso; Manuel Salinas-Navarro; Marta Agudo-Barriuso; Luis Alarcón-Martínez; Manuel Vidal-Sanz; María P Villegas-Pérez
Journal:  Mol Vis       Date:  2011-06-25       Impact factor: 2.367

5.  Retinal compensatory changes after light damage in albino mice.

Authors:  Luis Montalbán-Soler; Luis Alarcón-Martínez; Manuel Jiménez-López; Manuel Salinas-Navarro; Caridad Galindo-Romero; Fabrízio Bezerra de Sá; Diego García-Ayuso; Marcelino Avilés-Trigueros; Manuel Vidal-Sanz; Marta Agudo-Barriuso; Maria P Villegas-Pérez
Journal:  Mol Vis       Date:  2012-03-24       Impact factor: 2.367

6.  The influence of visible light exposure on cultured RGC-5 cells.

Authors:  John P M Wood; Gerassimos Lascaratos; Anthony J Bron; Neville N Osborne
Journal:  Mol Vis       Date:  2007-02-11       Impact factor: 2.367

7.  Removal of the blue component of light significantly decreases retinal damage after high intensity exposure.

Authors:  Javier Vicente-Tejedor; Miguel Marchena; Laura Ramírez; Diego García-Ayuso; Violeta Gómez-Vicente; Celia Sánchez-Ramos; Pedro de la Villa; Francisco Germain
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

8.  Iron oxides in novel skin care formulations attenuate blue light for enhanced protection against skin damage.

Authors:  Eric F Bernstein; Harry W Sarkas; Patricia Boland
Journal:  J Cosmet Dermatol       Date:  2020-11-18       Impact factor: 2.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.